Sequential generalized likelihood ratio tests for vaccine safety evaluation

Statistics in Medicine

Volumn 29, Issue 26, 2010, Pages 2698-2708

  Shih, Mei Chiung ^a,b   Lai, Tze Leung ^b   Heyse, Joseph F ^c   Chen, Jie ^d  

^a VA Cooperative Studies Program   (United States)

^b STANFORD UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Generalized likelihood ratio tests; Rotavirus; Sequential probability ratio test; Vaccine safety

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; GENERALIZED LIKELIHOOD RATIO TEST; HUMAN; ROTAVIRUS; SIMULATION; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT; VACCINATION;

ALGORITHMS; CLINICAL TRIALS AS TOPIC; DRUG TOXICITY; HUMANS; LIKELIHOOD FUNCTIONS; ROTAVIRUS; SAFETY MANAGEMENT; VACCINES;

EID: 77958517550     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4036     Document Type: Article

References (31)

1. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR. Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. New England Journal of Medicine 2001; 344:564-572.
2. Ellenberg SS, Foulkes MA, Midthun K, Goldenthal KL. Evaluating the safety of new vaccines: summary of a workshop. American Journal of Public Health 2005; 95:800-807. DOI: 10.2105/AJPH.2004.039438.
3. Wilson CB, Marcuse EK. Vaccine safety-vaccine benefits: science and the public's perception. Nature Reviews-Immunology 2001; 1:160-165. DOI: 10.1038/35100585.
4. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC, The Vaccine Safety Datalink Team. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997; 99:765-773. DOI: 10.1542/peds.99.6.765.
5. Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, Platt R, Black S, Shinefield H, Chen RT. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 2005; 16:336-341. DOI: 10.1097/01.ede.0000155506.05636.a4.
6. Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R. For the vaccine safety datalink rapid cycle analysis team. Real-time vaccine safety surveillance for the early detection of adverse events. Medical Care 2007; 45:S89-S95.
7. Heyse JF, Kuter B, Dallas MJ, Heaton P. Evaluating the safety of a rotavirus vaccine: the REST of the story. Clinical Trials 2008; 5:131-139. DOI: 10.1177/1740774508090507.
8. Abt K. Poisson sequential sampling modified towards maximal safety in adverse event monitoring. Biometrical Journal 1998; 40:21-41.
9. Bolland K, Whitehead J. Formal approaches to safety monitoring of clinical trials in life-threatening conditions. Statistics in Medicine 2000; 19:2899-2917.
10. Goldman AI, Hannan PJ. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm. Statistics in Medicine 2001; 20:1575-1589. DOI: 10.1002/sim.713.
11. Grigg OA, Farewell VT, Spiegelhalter DJ. Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Statistical Methods in Medical Research 2003; 12:147-170. DOI: 10.1177/096228020301200205.
12. Hocine MN, Musonda P, Andrews NJ, Farrington CP. Sequential case series analysis for pharmacovigilance. Journal of Royal Statistical Society A 2009; 170:213-236.
13. Chen RT, Davis RL, Rhodes PH. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In Pharmacoepidemiology (4th edn), Strom BL (ed.). Wiley: New York, 2005; 455-486.
14. Wald A. Sequential tests of statistical hypotheses. Annals of Mathematical Statistics 1945; 16:117-186.
15. Wald A, Wolfowitz J. Optimum character of the sequential probability ratio test. Annals of Mathematical Statistics 1948; 19:326-339.
16. Dvoretzky A, Kiefer J, Wolfowitz J. Sequential decision problems for processes with continuous time parameters. Annals of Mathematical Statistiscs 1953; 24:403-415.
17. Lai TL. Asymptotic optimality of generalized sequential likelihood ratio tests in some classical sequential testing procedures. In Handbook of Sequential Analysis, Ghosh BK, Sen PK (eds). Dekker: New York, 1991; 121-144.
18. Schwarz G. Asymptotic shapes of Bayes sequential testing regions. Annals of Mathematical Statistics 1962; 33:224-236.
19. Wong SP. Asymptotically optimal properties of certain sequential tests. Annals of Mathematical Statistics 1968; 39:1244-1263.
20. Lai TL. Nearly optimal sequential tests of composite hypotheses. Annals of Statistics 1988; 16:856-886.
21. Lai TL, Shih MC. Power, sample size and adaptation considerations in the design of group sequential clinical trials. Biometrika 2004; 91:507-528.
22. Murphy TV, Smith PJ, Gargiullo PM, Schwartz B. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. Journal of Infectious Diseases 2003; 187:1309-1313. DOI: 10.1086/374420.
23. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006; 354:23-33.
24. Lai TL. Sequential analysis: some classical problems and new challenges (with Discussion). Statistica Sinica 2001; 11:303-408.
25. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical tirals. Biometrika 1983; 70:659-663.
26. Page ES. Continuous inspection schemes. Biometrika 1954; 41:100-114.
27. Sonneson C, Bock D. A review and discussion of prospective statistical surveillance in public health. Journal of the Royal Statistical Society, Series A 2003; 166:5-21.
28. Frisén M. Optimal sequential surveillance for finance, public health, and other areas (with Discussion). Sequential Analysis 2009; 28:310-393.
29. Lai TL. Sequential changepoint detection in quality control and dynamical systems (with Discussion). Journal of the Royal Statistical Society, Series B 1995; 57:613-658.
30. Lai TL, Liu T, Xing H. A Bayesian approach to sequential surveillance in exponential families. Communications in Statistics-Theory and Methods (Special Issue in Honor of S. Zacks) 2009; 38:2958-2968.
31. Lai TL. Sequential change-point detection when the pre- and post-change parameters are unknown. Sequential Analysis 2010; 29:162-175.